NCT03265223View on ClinicalTrials.gov

Ropivacaine Use Intraincisionally Versus Intraperitoneally for Post-Laparoscopic Cholecystectomy Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

353

Participants

Timeline

Start Date

April 1, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

August 15, 2017

Conditions
RopivacaineLaparoscopic CholecystectomyPain
Interventions
DRUG

0.2% ropivacaine

Intraperitoneal instillation versus intraincisional infiltration

All Listed Sponsors
lead

Jawaharlal Nehru Medical College

OTHER

NCT03265223 - Ropivacaine Use Intraincisionally Versus Intraperitoneally for Post-Laparoscopic Cholecystectomy Pain | Biotech Hunter | Biotech Hunter